ex scientia is the first company to develop a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. This is achieved by either dialling-in extra desired targets to improve phenotypic response or removing unwanted off-targets to improve safety. We focus on exploiting our advanced design technologies to the development of a portfolio of bispecific drugs that tackle unmet medical need.
http://exscientia.co.uk/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.1 seconds
16x16
32x32
64x64
PAGES IN
THIS WEBSITE
4
SSL
EXTERNAL LINKS
3
SITE IP
198.49.23.145
LOAD TIME
1.078 sec
SCORE
6.2
ex scientia | exscientia.co.uk Reviews
https://exscientia.co.uk
ex scientia is the first company to develop a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. This is achieved by either dialling-in extra desired targets to improve phenotypic response or removing unwanted off-targets to improve safety. We focus on exploiting our advanced design technologies to the development of a portfolio of bispecific drugs that tackle unmet medical need.
exscientia.co.uk
Team — Exscientia Ltd
http://www.exscientia.co.uk/about
Andrew Hopkins - CEO. Adrian Schreyer - Head Molecular Informatics. Mark Swindells - COO. Jérémy Besnard - CTO. Senga Oxenham - Executive Officer. Willem van Hoorn - Head of Chemoinformatics. Richard Cox - Systems Architect. Richard Bickerton - CIO. Andy Bell - Chief Chemist. Richard Bickerton PhD - CIO. Mark Swindells PhD - COO. Prof Andrew Hopkins FRSE FRSC - CEO. Andrew spent 10 years at Pfizer, where he was responsible for establishing new research foci including the concepts of druggability and netw...
Bispecifics — Exscientia Ltd
http://www.exscientia.co.uk/bispecifics
Single compounds that independently bind two distinct targets. Most diseases are highly networked, so therapies often need to hit multiple nodes to have a sustainable effect. Furthermore, many drugs have now been shown to hit more than one target, suggesting that this. Is more frequent than previously anticipated. Exscientia have harnessed this knowledge to develop a system to design molecules that explicitly hit more than one target.
Portfolio — Exscientia Ltd
http://www.exscientia.co.uk/portfolio
Exscientia Ltd, Lab 12 - Dundee Incubator - James Lindsay Place, DD1 5JJ, United Kingdom.
News — Exscientia Ltd
http://www.exscientia.co.uk/news
April 26, 2016. Evotec and Exscientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics. April 26, 2016. Evotec AG and Exscientia Ltd today announced a research collaboration with the objective to discover and develop first-in-class bispecific small molecule immuno-oncology therapies. April 26, 2016. November 15, 2015. Exscientia named Young Business of the Year. November 15, 2015. November 15, 2015. October 2, 2015. October 2, 2015. October 2, 2015. September 2, 2015.
TOTAL PAGES IN THIS WEBSITE
4
Resources - MicroMatrices
http://www.micromatrices.com/resources
Frontiers, Not Boundaries. MicroMatrices is ideally situated in the heart of one of the most vibrant centers for biomedical research, as well as design, in the UK/Europe. As active partners within this community, MicroMatrices is positioned at the forefront of its field to bring its clients the benefits of new developments within our biotechnology/biomedical sector. For further insight into our scientific resource base, we provide the following references:. Wwwdrugdiscovery.dundee.ac.uk. On an interactiv...
TOTAL LINKS TO THIS WEBSITE
3
Exscience.com - Ready For Development
Contact Us for Details. If you're interested in this domain, contact us to check availability for ownership, customer use, partnership or other development opportunities. By continuing you agree to our Terms of Use. We respect your privacy and will keep your personal info confidential. Contact us to see if this domain is available with one of our monthly e-Inclusive Web Packages. Looking for another name? Choose Domain Only, Web Packages, or Other Services. 2018 Exscience.com Terms of Use.
Exercise Science
Exscien Corporation
Damage to mitochondrial DNA is a root cause. Of countless acute and chronic disorders Exscien has discovered a way. To repair this damage. Damage to mitochondrial DNA is a root cause. Of countless acute and chronic disorders. Exscien has discovered a way. To repair this damage. Damage to mitochondrial DNA is a root cause. Of countless acute and chronic disorders. Exscien has discovered a way. To repair this damage. A platform that restores health at the cellular. Level by repairing afflicted mitochondria.
hibu
This site was purchased through our premier business store. Check it out today! Hibu is here to help consumers find local businesses, browse products. And services and buy locally. With a broad range of digital services on offer, hibu can help small. Businesses compete in the online world in next to no time at all. Together, we can help communities thrive. Discover solutions that are easy. To use and knowledge to help your business thrive. Try our products for free. Promote your business today.
eXscient Technology
Information Systems Design and Development. Delivering corporate level IT service to organizations of all sizes. Contact us for information about our services.
ex scientia
Medicines tailored to polypharmacology. Medicines tailored to polypharmacology. The clinical efficacy and safety of a drug is determined by its activity profile across many proteins in the proteome. Is the first company to develop a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. This is achieved by either dialling-in extra desired targets to improve phenotypic response or removing unwanted off-targets to improve safety. And in particular a.
This Web site coming soon
If you are the owner of this web site you have not uploaded (or incorrectly uploaded) your web site. For information on uploading your web site using FTP client software or web design software, click here for FTP Upload Information.
ex scientia, veritas | From Knowledge, Truth
Ex scientia, veritas. From Knowledge, Truth. 17 March, 2009. 8221; We are actors in a moment of history, taking part in it, moving it this way or that as we move forward or back. The moment we are living now is a strange one, a disquieting one,. A time that seems full of endings. 8221; – Peggy Noonan, March 13 2009. Blog at WordPress.com. The Ocean Mist Theme. Follow “ex scientia, veritas”. Get every new post delivered to your Inbox. Build a website with WordPress.com.
esv
From science, knowledge. Cognitive science at the service of individuals, businesses, and governments.
exscientist.com | The Life After
The birth of a new site. Welcome to the birth of a new site. This has been in the making for well over 16 years plus or minus the time I wrote this. It is the result of a path set in motion by a great high school AP Biology teacher, a teacher that had an impact on my life and set in stone a love for the creativity and excitement hidden inside a clear tube. From other scientists who have left the research world to find other jobs and new directions. What did they do to find a way out? Be Sociable, Share!
HOME
1) The exscientologist that admires L Ron Hubbard. 2) The exscientologist that does NOT admire L Ron Hubbard. The exscientologist that admires L Ron Hubbard disconnected from Scientology because of his belief that there were suppressive people (SP’s) in the church. Many of these people - the social personalities - have become affiliated with the Freezone. Link1 to Marty Rathbun - high ranking exscientologist. Link2 to Marty Rathbun - high ranking exscientologist.
SOCIAL ENGAGEMENT